ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,119.37
0.38%
US Tech 100
17,286.40
0.27%
Dow Jones
38,351.33
0.29%
Brent Oil
87.855
0.20%
Bitcoin
62,400.00
-0.95%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Cellectis Nom Eo 05 (ALCLS) Quote

Cellectis Nom Eo 05

Cellectis Nom Eo 05 (ALCLS)

EU
2.37
0.025
( 1.07% )
Updated: 09:48:46
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.37
Bid
2.37
Ask
2.38
Volume
33,994
2.35 Day's Range 2.44
0.888 52 Week Range 3.44
Market Cap
186.553M
Previous Close
2.345
Open
2.35
Last Trade
270
@
2.37
Last Trade Time
09:54:48
Financial Volume
-
VWAP
-
Average Volume (3m)
85,434
Shares Outstanding
71,751,201
Dividend Yield
-
PE Ratio
-1.76
Earnings Per Share (EPS)
-1.48
Revenue
27.67M
Net Profit
-106.14M

About Cellectis Nom Eo 05

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cellectis.com
Headquarters
Paris, Paris, Fra
Founded
1970
Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 2.35 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 0.888 € to 3.44 €.

Cellectis Nom Eo 05 currently has 71,751,201 shares outstanding. The market capitalization of Cellectis Nom Eo 05 is 186.55 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -1.76.

ALCLS Latest News

More News

Cellectis présente de nouveaux procédés d’éditions par TALEN® permettant une insertion et une correction du génome très efficaces dans les cellules souches progénitrices et hématopoïétiques (CSPHs)

Cellectis présente de nouveaux procédés d’éditions par TALEN® permettant une insertion et une correction du génome très efficaces dans les cellules souches progénitrices et hématopoïétiques...

April 22 2024
GlobeNewswire Inc.

Cellectis publie une nouvelle approche d'édition intronique pour le traitement des maladies métaboliques congénitales par des cellules souches hématopoïétiques modifiées

Cellectis publie une nouvelle approche d'édition intronique pour le traitement des maladies métaboliques congénitales par des cellules souches hématopoïétiques modifiées NEW YORK, 10...

April 10 2024
GlobeNewswire Inc.

Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs

Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (the...

April 10 2024
GlobeNewswire Inc.

Cellectis présentera deux posters sur un nouveau procédé d’édition par TALEN® pour la correction et l’insertion de gènes dans les cellules souches et progénitrices hématopoïétiques (HSPCs) à l’ASGCT

Cellectis présentera deux posters sur un nouveau procédé d’édition par TALEN® pour la correction et l’insertion de gènes dans les cellules souches et progénitrices hématopoïétiques (HSPCs) à...

April 08 2024
GlobeNewswire Inc.

Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

April 08 2024
GlobeNewswire Inc.

CORRECTION : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

CORRECTION : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés...

April 04 2024
GlobeNewswire Inc.

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, April 04, 2024 (GLOBE NEWSWIRE...

April 04 2024
GlobeNewswire Inc.

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 04...

April 04 2024
GlobeNewswire Inc.

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights PARIS, March 04, 2024 (GLOBE NEWSWIRE) -- (Article 223-16 of General Regulation of the French financial markets authority...

March 04 2024
GlobeNewswire Inc.

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social       (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers...

February 02 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.035-1.45530145532.4052.52.32364482.40422565DE
4-0.13-5.22.52.7352.27688792.47792766DE
12-0.242-9.264931087292.6122.882.126854342.47968139DE
261.42149.4736842110.953.440.8972697902.63823698DE
520.5731.66666666671.83.440.8881757602.41337309DE
156-13.23-84.807692307715.616.390.8881686933.99904969DE
260-15.34-86.61773009617.7128.450.8881399097.10788009DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DCPHDeciphera Pharmaceuticals Inc
$ 25.325
(72.87%)
31.16M
CAUDCollective Audience Inc
$ 0.6105
(56.54%)
46.22M
SINTSiNtx Technologies Inc
$ 0.0556
(37.62%)
64.73M
SLNOSoleno Therapeutics Inc
$ 50.70
(33.81%)
929.62k
HWHHWH International Inc
$ 2.4069
(32.25%)
5.71M
CLVRClever Leaves Holdings Inc
$ 1.74
(-57.66%)
414.53k
ADXNAddex Therapeutics Ltd
$ 8.77
(-45.53%)
68.35k
IONMAssure Holdings Corporation
$ 0.4975
(-28.52%)
688.68k
MFImF International Ltd
$ 1.7797
(-23.62%)
1.49M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 31.0915
(-20.83%)
2.83M
SOFISoFi Technologies Inc
$ 7.1852
(-8.70%)
65.69M
SINTSiNtx Technologies Inc
$ 0.0553
(36.88%)
64.72M
TSLATesla Inc
$ 185.90
(10.46%)
61.04M
CAUDCollective Audience Inc
$ 0.6105
(56.54%)
46.21M
AKANAkanda Corporation
$ 0.1063
(3.20%)
31.29M

Discussion

View Full Feed
ss0722 ss0722 3 minutes ago
Solray apparently exists. At least they answer the phone with a real person - 888 381 4744
SNPW
DCorleone DCorleone 3 minutes ago
NSAV is going to hurt.... "HARD" GLTA
NSAV
researcher59 researcher59 3 minutes ago
TDAM to Schwab definitely seems like a downgrade to me. Fortunately E*Trade offers the 4 year analyst EPS estimates changes history that Ameritrade had, but not Schwab. Even Yahoo is better than Schwab with that feature.

Also Ameritrade saves the transaction history going back over
Doubledown75 Doubledown75 3 minutes ago
Making all hedge funds primary dealers of UST, now we know why that is…..boj would have to sell ust to intervene like they say. I’d much rather they do something with gold than to go cbdc.
GOLD
murrayhill murrayhill 3 minutes ago
Reverend Gary Davis - I'll Fly Away
https://www.youtube.com/watch?v=6PgEBmffwGw
Chartmaster Chartmaster 3 minutes ago
.01 !!! There it is! .01 chart target achieved! Who said charts don't work in OTC? oh, it was the guy who sold 30, the self proclaimed "Crypto-Expert" !!! Lmao!!!
NSAV
Xrouter Xrouter 4 minutes ago
As long as they can push this over $3 US a share. Then it’s Adios Amigos.
POET
shurtha2000 shurtha2000 4 minutes ago
PEGY .064 could go nutso if this gets any govt orders or contracts
PEGY
Nighthawk_1 Nighthawk_1 4 minutes ago
Well, that is how I feel. My feeling count too, you know...LOL Not one I will be getting into yet until the real drop, but will be observing.
AVAI
pack10 pack10 4 minutes ago
I seem to recall a movie where they were sayings; IT"S COMPLICATED!!
From what I gathered you suggest the CME might just produce paper without having the actual silver. That would seem to go against the rules.
These silver manipulators have moved, smashed if you will, the con
ZSL
jeunke22 jeunke22 4 minutes ago
yes, because they are in passive organic polymers for displays ( TV, Iphones,computer screen etc) and Lebby often has referenced their business model as being what Lightwave had in mind. . Interesting comparison for several reasons. One, the OLED market is dominated by two Tier 1 companies : Samsun
LWLG
StockItOut StockItOut 4 minutes ago
One-fourth of the 2B previously conveyed is deflating. Even the Rosy Story Crew are mute, confused on how to spin-positive a let down (but this might get them going).
MDCE
cojoboy cojoboy 4 minutes ago
For Your sake..I hope it does..for My sake..I hope it doesn't.. Lol
IGPK
Agoura Guy Agoura Guy 4 minutes ago
PUMPTARDS PROVIDING ANOTHER SETUP!!!!!!!!

THEY CAN'T HELP THEMSELVES!!!!!!!

SPY
ANTI-BAGHOLDER ANTI-BAGHOLDER 4 minutes ago
This gway scum bag is full of lies.
TGGI
Huggy Bear Huggy Bear 4 minutes ago
All sorts of criminals up in here snow.
SPZI
nathanial nathanial 4 minutes ago
Shouldn't it take a few weeks for the final completion of the submission report by PearlPathways before actual submission to the FDA?
RDGL
jimmybob jimmybob 4 minutes ago
https://x.com/OMillionaires/status/1784948948039278904
ilovetech ilovetech 4 minutes ago
How about that proposed 44.6% capital gains tax?
NWBO
nowwhat2 nowwhat2 4 minutes ago
Indeed that sounds familiar so, don't tell me tell HIM
BTCUSD
tutt1126 tutt1126 4 minutes ago
What is going on with pps?
FNMA
jimmybob jimmybob 4 minutes ago
UPB in da HIZZLE
FLA FLA 4 minutes ago
$BDPT .0003 ^10%
BDPT

Your Recent History

EU
ALCLS
Cellectis Nom Eo 05
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved